Atlas Trials

Effectiveness and Safety of Therapy Based on Attenuated ATO Plus Low-Dose ATRA in Patients With APL

Clinical trial NCT05497310 · UNKNOWN

Trial details

NCT number
NCT05497310
Sponsor
Hospital Universitario Dr. Jose E. Gonzalez
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Promyelocytic Leukemia
Start date
2022-07-01
Primary completion
2025-06-30
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.